Feature | Thrombectomy Devices | September 02, 2015

Larger Thrombi Retrieval Associated with Improved Neurological Recovery After Stroke

Sub-study of MR CLEAN trial suggests that retrieving larger thrombi may be better than retrieving large numbers of smaller particles
 

acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study

September 2, 2015 — Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery after acute ischemic stroke, according to a sub-study of the MR CLEAN trial. Results of the sub-study were presented at the European Society of Cardiology (ESC) Congress 2015 by Anouchska Autar, Ph.D. candidate at the Erasmus Medical Centre in Rotterdam, the Netherlands.

“Acute ischemic strokes occur when a blood clot, also called a thrombus, embolizes to the brain where it restricts the flow of blood,” said Autar. “MR CLEAN was the first trial to show the benefit of IAT to remove blood clots within six hours after a stroke. IAT, which was given against a background of standard care including intravenous tissue plasminogen activator if indicated, led to better restoration of blood flow and improved functional outcome when compared to no IAT.”

Thrombi retrieved during the MR CLEAN trial were collected for the current sub-study to investigate the relationship between the macroscopic appearance of thrombi retrieved during IAT, cause of stroke and clinical outcome. Measures of macroscopic appearance included length, width, area and numbers of particles the thrombus had broken into.

Neurological recovery was assessed using the National Institutes of Health Stroke Severity Scale (NIHSS).

The study included 35 collections of thrombi from 35 patients who had undergone IAT after an acute ischemic stroke. Most of the patients had a severe stroke, of which 49 percent were of cardiac origin and 20 percent were due to atherosclerosis.

The researchers found that patients whose stroke was caused by atherosclerosis had significantly longer and larger thrombi (p=0.0035 and p=0.045, respectively) than those with stroke from other causes. “This could be because patients with atherosclerosis have more diseased arteries and this may influence thrombus size,” said Autar.

They also found that patients from whom longer and wider thrombi were retrieved had significantly improved neurological recovery at discharge after IAT compared to those with smaller thrombi (p=0.03 and p=0.04, respectively). “This finding is particularly important because it indicates that the larger the pieces that you retrieve, the better this is for your patient,” said Autar.

Interestingly, an increased number of particles retrieved during IAT showed a trend towards a worse neurological recovery at discharge, although the association was not significant (p=0.079). Autar said: “Together, this suggests that some emboli are more likely to disintegrate and the smaller particles may embolize and obstruct the microvasculature of the brain, leading to incomplete recovery.”

She concluded: “Our study shows that retrieval of larger thrombi during IAT is associated with improved neurological recovery at discharge in patients with acute ischemic stroke. The findings indicate that a simple parameter such as thrombus size might influence the decision to give or refrain from additional thrombolysis. This needs to be verified of course in larger trials.”

For more information: http://www.escardio.org/

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init